Barry Goldman

Barry Goldman has a strong background in the field of microbial discovery and research. Barry currently holds the role of Chief Scientific Officer at Pluton Biosciences, where they are responsible for leading scientific strategy for microbial discovery. Prior to this, they served as the Chief Executive Officer at the same company.

Before joining Pluton Biosciences, Barry worked at Indigo as the Vice President of Research from 2016 to 2019. In this role, they led the microbial testing pipeline for a large and innovative agriculture company, overseeing processes from isolation and sequencing to testing effects on plant phenotypes.

Barry's extensive experience also includes a significant tenure at Monsanto Company, where they held multiple roles starting from 1999. Barry served as the Microbial Discovery Lead, responsible for all microbial and gene discovery for the company's biotechnology pipelines. Barry developed a population genomics approach to gene discovery, increasing the throughput of the current process. Additionally, Barry developed state-of-the-art decision-making pipelines through the analysis and visualization of 16S and whole genome information. Barry also played a key role in developing machine-learning algorithms to identify novel modes-of-action for the biotechnology pipeline.

During their time at Monsanto, Barry held various positions including Research Fellow, Genome Analytics Platform Lead, Technology Prospecting Lead, and Bioinformatics specialist. In these roles, they successfully managed teams, upgraded legacy systems, implemented computational systems, and delivered concise reports on competitive intelligence.

Barry's work experience also includes a brief period at Cereon Genomics/Monsanto as a Senior Scientist.

Overall, Barry Goldman's work experience showcases their expertise in microbial discovery, gene discovery, data analytics, and leadership in the biotechnology industry.

Barry Goldman's education history includes a Bachelor of Science degree in Botany from the University of Washington. Additionally, they pursued a PhD in Biology from the University of Utah. No specific start or end years were provided for their time at either university.